John H Stone Selected Research

Rituximab (Mabthera)

3/2023	B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives.
1/2023	Treatment of IgG4-related disease-associated hypertrophic pachymeningitis with intrathecal rituximab: a case report.
1/2023	Comparative Effectiveness of Rituximab- Versus Cyclophosphamide-Based Remission Induction Strategies in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the Risk of Kidney Failure and Mortality.
1/2023	Risk factors for serious infections in ANCA-associated vasculitis.
1/2023	Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
1/2023	Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism.
1/2023	Development and Validation of a Simulation Model for Treatment to Maintain Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
1/2022	Clinical Perspectives on IgG4-Related Disease and Its Classification.
10/2021	Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis.
1/2020	Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John H Stone Research Topics

Disease

72	Immunoglobulin G4-Related Disease 04/2024 - 01/2012
46	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2024 - 07/2004
46	Vasculitis (Vasculitides) 07/2023 - 01/2003
40	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 02/2024 - 08/2003
32	Giant Cell Arteritis (Horton Disease) 12/2023 - 05/2002
14	Inflammation (Inflammations) 01/2023 - 04/2005
13	Fibrosis (Cirrhosis) 03/2024 - 05/2011
12	Microscopic Polyangiitis 02/2024 - 07/2004
8	Infections 03/2023 - 05/2007
7	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 06/2011
7	Neoplasms (Cancer) 01/2023 - 05/2006
6	COVID-19 01/2022 - 12/2020
5	Rheumatoid Arthritis 06/2022 - 04/2005
4	Myocardial Infarction 01/2023 - 04/2011
4	Chronic Kidney Failure (Chronic Renal Failure) 10/2022 - 01/2018
4	Hemorrhage 11/2019 - 07/2010
4	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2019 - 01/2012
4	Glomerulonephritis 10/2018 - 01/2012
4	Aortitis 10/2017 - 10/2009
3	Asthma (Bronchial Asthma) 07/2023 - 01/2021
3	Meningitis 01/2023 - 08/2012
3	Sialadenitis 04/2022 - 02/2010
3	Stroke (Strokes) 12/2021 - 04/2011
3	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021 - 07/2004
3	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2021 - 10/2004
3	Body Weight (Weight, Body) 12/2020 - 05/2007
3	Fatigue 01/2019 - 06/2008
3	Eosinophilia 07/2015 - 01/2014
3	Chronic Disease (Chronic Diseases) 02/2015 - 06/2007
2	Muscular Diseases (Myopathy) 03/2023 - 01/2023
2	Rheumatic Diseases (Rheumatism) 02/2023 - 06/2022
2	Renal Insufficiency (Renal Failure) 01/2023 - 01/2018
2	Diabetes Mellitus 01/2023 - 07/2005
2	Systemic Scleroderma (Systemic Sclerosis) 09/2022 - 01/2020
2	Weight Gain 04/2022 - 05/2008
2	Shock 01/2022 - 01/2022
2	Hypersensitivity (Allergy) 01/2022 - 01/2014
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2012
2	Macrophage Activation Syndrome 01/2022 - 01/2022
2	Aneurysm (Aneurysms) 01/2022 - 01/2022
2	Retroperitoneal Fibrosis 11/2021 - 10/2018
2	Venous Thromboembolism 11/2019 - 01/2017
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 05/2019 - 10/2015

Drug/Important Bio-Agent (IBA)

58	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2024 - 07/2004
49	Immunoglobulin G (IgG)IBA 04/2024 - 02/2010
46	Rituximab (Mabthera)FDA Link 03/2023 - 01/2005
44	GlucocorticoidsIBA 04/2024 - 05/2007
23	tocilizumab (atlizumab)FDA Link 12/2023 - 01/2013
16	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 05/2005
15	Biomarkers (Surrogate Marker)IBA 02/2023 - 06/2011
15	Etanercept (Enbrel)FDA Link 12/2016 - 08/2003
13	Myeloblastin (Proteinase 3)IBA 02/2023 - 04/2011
12	Prednisone (Sone)FDA LinkGeneric 12/2023 - 01/2013
11	AutoantibodiesIBA 12/2023 - 04/2005
8	AntibodiesIBA 01/2023 - 05/2007
7	Azathioprine (Imuran)FDA LinkGeneric 01/2023 - 05/2005
7	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 05/2002
6	SteroidsIBA 03/2023 - 01/2012
6	Peroxidase (Myeloperoxidase)IBA 02/2023 - 04/2011
6	AntigensIBA 01/2023 - 01/2012
6	AutoantigensIBA 01/2022 - 01/2006
6	CytokinesIBA 01/2022 - 01/2013
6	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 01/2012
5	Immunoglobulin E (IgE)IBA 01/2022 - 01/2014
4	Granzymes (Granzyme)IBA 12/2023 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2004
4	Interleukin-6 (Interleukin 6)IBA 10/2021 - 01/2013
4	EnzymesIBA 01/2020 - 11/2007
4	InterleukinsIBA 05/2017 - 01/2013
4	Methotrexate (Mexate)FDA LinkGeneric 10/2015 - 05/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2011 - 01/2003
3	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 01/2023
3	Indicators and Reagents (Reagents)IBA 04/2022 - 12/2015
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2020 - 01/2013
3	Infliximab (Remicade)FDA Link 06/2011 - 05/2007
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023 - 01/2018
2	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2022
2	avacopanIBA 07/2023 - 03/2023
2	Immunoglobulin M (IgM)IBA 01/2023 - 11/2013
2	C-Reactive ProteinIBA 06/2022 - 11/2021
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2022
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2022
2	Peptide Hydrolases (Proteases)FDA Link 11/2021 - 01/2017
2	Immunologic Factors (Immunomodulators)IBA 10/2021 - 01/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 08/2013
2	CollagenIBA 01/2020 - 12/2015
2	ImmunosorbentsIBA 01/2020 - 11/2007
2	ChemokinesIBA 01/2020 - 12/2018
2	Galectin 3 (LGALS3)IBA 01/2020 - 01/2019
2	TinIBA 05/2019 - 10/2015
2	Phospholipase A2 ReceptorsIBA 05/2019 - 01/2012

Therapy/Procedure

43	Therapeutics 03/2024 - 01/2002
10	Remission Induction 03/2023 - 01/2005
3	Artificial Respiration (Mechanical Ventilation) 10/2021 - 10/2018
3	Biological Therapy 09/2019 - 01/2013
3	Aftercare (After-Treatment) 01/2018 - 12/2011
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2023 - 04/2011
2	Kidney Transplantation 12/2021 - 01/2018
2	Immunomodulation 01/2021 - 06/2011